Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain
NCT07559682Phase 1Active, not recruiting
- Sponsor
- Sharif Medical Research Center
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of etoricoxib in orthodontic pain (2 arms), sponsored by Sharif Medical Research Center. Primary endpoint: Pain intensity at 1 year. Started May 2025; status: active, not recruiting.
02
Drugs
etoricoxib
03
Conditions
orthodontic pain
Beyond the preview
Go deeper on NCT07559682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07559682.